EC 3.4.21.68: t-Plasminogen activator
HydrolasesOpen in Browse
CatLog read 194 records for EC 3.4.21.68 from 6 papers, for 2 organisms. Names in these papers: tissue type plasminogen activator (t-PA), tissue-type plasminogen activator (tPA), tissue-type plasminogen activator (single-chain tPA), tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA) and 2 more.
Read from the paper by an AI model and checked against the paper by a second, separate AI run; code converted the units.
CatLog also holds 9 records for EC 3.4.21.68 that are not yet re-read: from its earlier version, built from the enzyme databases and partly checked against the papers. All records for EC 3.4.21.68 in Browse.
Papers
Records
| Enzyme | Organism | Substrate | kcat (s⁻¹) | Km (mM) | kcat/Km (mM⁻¹ s⁻¹) | Conditions | Paper | Open record |
|---|---|---|---|---|---|---|---|---|
| tissue plasminogen activator (tPA) | — | H-D-Ile-Pro-Arg-pNA | 10.7 | 0.694 | 15 | PMID 17408411 | Open record: tissue plasminogen activator (tPA), H-D-Ile-Pro-Arg-pNA | |
| tissue plasminogen activator (tPA) | — | plasminogenplasminogen activation in buffer; no promoter | — | — | 27 | PMID 17408411 | Open record: tissue plasminogen activator (tPA), plasminogen | |
| tissue plasminogen activator (tPA) | — | plasminogen | — | — | 140 | PMID 17408411 | Open record: tissue plasminogen activator (tPA), plasminogen | |
| tissue plasminogen activator (tPA) | — | plasminogenplasminogen activation in fibrin clots; apparent kcat | 0.027 | 1.09 × 10⁻⁴ | 250 | PMID 17408411 | Open record: tissue plasminogen activator (tPA), plasminogen | |
| tissue plasminogen activator (tPA) | — | plasminogenplasminogen activation in fibrin clots; apparent kcat | 0.026 | 3.62 × 10⁻⁴ | 70 | PMID 17408411 | Open record: tissue plasminogen activator (tPA), plasminogen | |
| tissue plasminogen activator (tPA) | — | plasminogenplasminogen activation in fibrin clots; apparent kcat | 0.028 | 1.19 × 10⁻⁴ | 240 | PMID 17408411 | Open record: tissue plasminogen activator (tPA), plasminogen | |
| tissue plasminogen activator (tPA)variant R275E (sctPA) | — | H-D-Ile-Pro-Arg-pNA | 7.3 | 1.46 | 5 | PMID 17408411 | Open record: tissue plasminogen activator (tPA) variant R275E (sctPA), H-D-Ile-Pro-Arg-pNA | |
| tissue plasminogen activator (tPA)variant R275E (sctPA) | — | plasminogenplasminogen activation in buffer; no promoter | — | — | 4 | PMID 17408411 | Open record: tissue plasminogen activator (tPA) variant R275E (sctPA), plasminogen | |
| tissue plasminogen activator (tPA)variant R275E (sctPA) | — | plasminogen | — | — | 160 | PMID 17408411 | Open record: tissue plasminogen activator (tPA) variant R275E (sctPA), plasminogen | |
| tissue plasminogen activator (tPA)variant R275E (sctPA) | — | plasminogenplasminogen activation in fibrin clots; apparent kcat | 0.023 | 8.7 × 10⁻⁵ | 270 | PMID 17408411 | Open record: tissue plasminogen activator (tPA) variant R275E (sctPA), plasminogen | |
| tissue plasminogen activator (tPA)variant R275E (sctPA) | — | plasminogenplasminogen activation in fibrin clots; apparent kcat | 0.024 | 3.41 × 10⁻⁴ | 70 | PMID 17408411 | Open record: tissue plasminogen activator (tPA) variant R275E (sctPA), plasminogen | |
| tissue plasminogen activator (tPA)variant R275E (sctPA) | — | plasminogenplasminogen activation in fibrin clots; apparent kcat | 0.023 | 8.6 × 10⁻⁵ | 270 | PMID 17408411 | Open record: tissue plasminogen activator (tPA) variant R275E (sctPA), plasminogen | |
| tissue type plasminogen activator (t-PA) | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.1 | 1.1 × 10⁻⁵ | 9.1 × 10³ | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA), Lys-plasminogen | |
| tissue type plasminogen activator (t-PA) | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 0.068 | 0.005 | 14 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA), Lys-plasminogen | |
| tissue type plasminogen activator (t-PA) | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 47 | 0.4 | 120 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA), methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant F423A | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.12 | 1.4 × 10⁻⁵ | 8.6 × 10³ | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant F423A, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant F423A | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 0.02 | 0.004 | 5 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant F423A, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant F423A | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 49 | 0.5 | 98 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant F423A, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant F423A/R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.2 | 2.2 × 10⁻⁵ | 9.1 × 10³ | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant F423A/R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant F423A/R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 0.004 | 0.01 | 0.4 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant F423A/R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant F423A/R275E | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 27 | 1 | 27 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant F423A/R275E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant F423E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.18 | 2.3 × 10⁻⁵ | 7.8 × 10³ | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant F423E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant F423E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 0.017 | 0.005 | 3.4 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant F423E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant F423E | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 57 | 0.5 | 110 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant F423E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant F423E/R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.15 | 1.5 × 10⁻⁵ | 1 × 10⁴ | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant F423E/R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant F423E/R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 0.003 | 0.008 | 0.38 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant F423E/R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant F423E/R275E | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 28 | 0.9 | 31 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant F423E/R275E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant L420A | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.17 | 1.9 × 10⁻⁵ | 8.9 × 10³ | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant L420A, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant L420A | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 0.014 | 0.001 | 14 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant L420A, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant L420A | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 45 | 0.4 | 110 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant L420A, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant L420A/R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.18 | 1.4 × 10⁻⁵ | 1.3 × 10⁴ | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant L420A/R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant L420A/R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 0.008 | 0.009 | 0.89 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant L420A/R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant L420A/R275E | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 42 | 1.3 | 32 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant L420A/R275E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant L420E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.17 | 2.1 × 10⁻⁵ | 8.1 × 10³ | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant L420E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant L420E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 0.005 | 7 × 10⁻⁴ | 7.1 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant L420E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant L420E | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 45 | 0.4 | 110 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant L420E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant L420E/R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.15 | 1.8 × 10⁻⁵ | 8.3 × 10³ | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant L420E/R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant L420E/R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 0.002 | 0.005 | 0.4 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant L420E/R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant L420E/R275E | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 29 | 0.9 | 32 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant L420E/R275E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant P422A | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.11 | 1.3 × 10⁻⁵ | 8.5 × 10³ | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant P422A, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant P422A | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 0.028 | 0.004 | 7 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant P422A, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant P422A | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 47 | 0.4 | 120 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant P422A, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant P422A/R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.15 | 1 × 10⁻⁵ | 1.5 × 10⁴ | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant P422A/R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant P422A/R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 0.007 | 0.013 | 0.54 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant P422A/R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant P422A/R275E | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 32 | 1.2 | 27 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant P422A/R275E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant P422E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.15 | 2.9 × 10⁻⁵ | 5.2 × 10³ | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant P422E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant P422E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 0.0015 | 7 × 10⁻⁴ | 2.1 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant P422E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant P422E | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 49 | 0.4 | 120 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant P422E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant P422E/R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.17 | 2.8 × 10⁻⁵ | 6.1 × 10³ | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant P422E/R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant P422E/R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 5 × 10⁻⁴ | 0.005 | 0.1 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant P422E/R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant P422E/R275E | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 31 | 1.1 | 28 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant P422E/R275E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant P422G | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.15 | 2.6 × 10⁻⁵ | 5.8 × 10³ | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant P422G, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant P422G | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 0.0028 | 6 × 10⁻⁴ | 4.7 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant P422G, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant P422G | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 60 | 0.6 | 100 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant P422G, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant P422G/R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.21 | 2.7 × 10⁻⁵ | 7.8 × 10³ | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant P422G/R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant P422G/R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 8 × 10⁻⁴ | 0.004 | 0.2 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant P422G/R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant P422G/R275E | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 14 | 1.7 | 8.2 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant P422G/R275E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.13 | 1 × 10⁻⁵ | 1.3 × 10⁴ | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 0.024 | 0.017 | 1.4 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant R275E | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 33 | 1 | 33 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant R275E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant S421E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.15 | 1.8 × 10⁻⁵ | 8.3 × 10³ | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant S421E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant S421E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 0.016 | 0.003 | 5.3 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant S421E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant S421E | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 46 | 0.4 | 120 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant S421E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant S421E/R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.21 | 2.3 × 10⁻⁵ | 9.1 × 10³ | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant S421E/R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant S421E/R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 0.002 | 0.007 | 0.29 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant S421E/R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant S421E/R275E | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 26 | 2.3 | 11 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant S421E/R275E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant S421G | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.11 | 1.6 × 10⁻⁵ | 6.9 × 10³ | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant S421G, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant S421G | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 0.018 | 0.004 | 4.5 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant S421G, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant S421G | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 36 | 0.4 | 90 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant S421G, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue type plasminogen activator (t-PA)variant S421G/R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.0125-0.2 µM | 0.19 | 2.6 × 10⁻⁵ | 7.3 × 10³ | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant S421G/R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant S421G/R275E | Homo sapiens | Lys-plasminogenLys-plasminogen varied 0.9-15 µM | 0.001 | 0.004 | 0.25 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant S421G/R275E, Lys-plasminogen | |
| tissue type plasminogen activator (t-PA)variant S421G/R275E | Homo sapiens | methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | 23 | 4.6 | 5 | PMID 8999865 | Open record: tissue type plasminogen activator (t-PA) variant S421G/R275E, methylsulfonyl-D-cyclohexyltyrosyl-glycyl-arginine-p-nitroaniline | |
| tissue-type plasminogen activator (single-chain tPA) | Homo sapiens | D-alpha-aspartyl-glycyl-L-arginine 4-nitroanilide | 0.43 | 1.7 | 0.25 | pH 8, 25 °C | PMID 9268299 | Open record: tissue-type plasminogen activator (single-chain tPA), D-alpha-aspartyl-glycyl-L-arginine 4-nitroanilide |
| tissue-type plasminogen activator (single-chain tPA) | Homo sapiens | D-alpha-glutamyl-glycyl-L-arginine 4-nitroanilide | 3.98 | 2.9 | 1.37 | pH 8, 25 °C | PMID 9268299 | Open record: tissue-type plasminogen activator (single-chain tPA), D-alpha-glutamyl-glycyl-L-arginine 4-nitroanilide |
| tissue-type plasminogen activator (single-chain tPA) | Homo sapiens | D-cyclohexylglycyl-glycyl-L-arginine 4-nitroanilide | 6.74 | 1.53 | 4.4 | pH 8, 25 °C | PMID 9268299 | Open record: tissue-type plasminogen activator (single-chain tPA), D-cyclohexylglycyl-glycyl-L-arginine 4-nitroanilide |
| tissue-type plasminogen activator (single-chain tPA) | Homo sapiens | D-hexahydrotyrosyl-glycyl-L-arginine 4-nitroanilide | 10.6 | 0.83 | 12.8 | pH 8, 25 °C | PMID 9268299 | Open record: tissue-type plasminogen activator (single-chain tPA), D-hexahydrotyrosyl-glycyl-L-arginine 4-nitroanilide |
| tissue-type plasminogen activator (single-chain tPA) | Homo sapiens | D-lysyl-glycyl-L-arginine 4-nitroanilide | 6.32 | 2.1 | 3.01 | pH 8, 25 °C | PMID 9268299 | Open record: tissue-type plasminogen activator (single-chain tPA), D-lysyl-glycyl-L-arginine 4-nitroanilide |
| tissue-type plasminogen activator (single-chain tPA) | Homo sapiens | D-phenylalanyl-glycyl-L-arginine 4-nitroanilide | 7.46 | 0.7 | 10.7 | pH 8, 25 °C | PMID 9268299 | Open record: tissue-type plasminogen activator (single-chain tPA), D-phenylalanyl-glycyl-L-arginine 4-nitroanilide |
| tissue-type plasminogen activator (single-chain tPA) | Homo sapiens | L-alpha-aspartyl-glycyl-L-arginine 4-nitroanilide | 0.28 | 0.86 | 0.32 | pH 8, 25 °C | PMID 9268299 | Open record: tissue-type plasminogen activator (single-chain tPA), L-alpha-aspartyl-glycyl-L-arginine 4-nitroanilide |
| tissue-type plasminogen activator (single-chain tPA) | Homo sapiens | L-alpha-glutamyl-glycyl-L-arginine 4-nitroanilide | 0.13 | 3.2 | 0.041 | pH 8, 25 °C | PMID 9268299 | Open record: tissue-type plasminogen activator (single-chain tPA), L-alpha-glutamyl-glycyl-L-arginine 4-nitroanilide |
| tissue-type plasminogen activator (single-chain tPA) | Homo sapiens | L-cyclohexylglycyl-glycyl-L-arginine 4-nitroanilide | 1.36 | 5.32 | 0.26 | pH 8, 25 °C | PMID 9268299 | Open record: tissue-type plasminogen activator (single-chain tPA), L-cyclohexylglycyl-glycyl-L-arginine 4-nitroanilide |
| tissue-type plasminogen activator (single-chain tPA) | Homo sapiens | L-phenylalanyl-glycyl-L-arginine 4-nitroanilide | 2.79 | 2 | 1.4 | pH 8, 25 °C | PMID 9268299 | Open record: tissue-type plasminogen activator (single-chain tPA), L-phenylalanyl-glycyl-L-arginine 4-nitroanilide |
| tissue-type plasminogen activator (single-chain tPA) | Homo sapiens | N-benzyloxycarbonyl-D-alpha-aspartyl(beta-tert-butyl ester)-glycyl-L-arginine 4-nitroanilide | 4.98 | 1.8 | 2.77 | pH 8, 25 °C | PMID 9268299 | Open record: tissue-type plasminogen activator (single-chain tPA), N-benzyloxycarbonyl-D-alpha-aspartyl(beta-tert-butyl ester)-glycyl-L-arginine 4-nitroanilide |
| tissue-type plasminogen activator (single-chain tPA) | Homo sapiens | N-benzyloxycarbonyl-D-alpha-glutamyl(gamma-tert-butyl ester)-glycyl-L-arginine 4-nitroanilide | 4.48 | 1.2 | 3.73 | pH 8, 25 °C | PMID 9268299 | Open record: tissue-type plasminogen activator (single-chain tPA), N-benzyloxycarbonyl-D-alpha-glutamyl(gamma-tert-butyl ester)-glycyl-L-arginine 4-nitroanilide |
| tissue-type plasminogen activator (single-chain tPA) | Homo sapiens | N-benzyloxycarbonyl-D-alpha-glutamyl-glycyl-L-arginine 4-nitroanilide | 7.46 | 2.6 | 2.87 | pH 8, 25 °C | PMID 9268299 | Open record: tissue-type plasminogen activator (single-chain tPA), N-benzyloxycarbonyl-D-alpha-glutamyl-glycyl-L-arginine 4-nitroanilide |
| tissue-type plasminogen activator (single-chain tPA) | Homo sapiens | N-benzyloxycarbonyl-D-arginyl-glycyl-L-arginine 4-nitroanilide | 8.53 | 0.52 | 16.4 | pH 8, 25 °C | PMID 9268299 | Open record: tissue-type plasminogen activator (single-chain tPA), N-benzyloxycarbonyl-D-arginyl-glycyl-L-arginine 4-nitroanilide |
| tissue-type plasminogen activator (single-chain tPA) | Homo sapiens | N-benzyloxycarbonyl-D-phenylalanyl-glycyl-L-arginine 4-nitroanilide | 8.96 | 0.3 | 19.9 | pH 8, 25 °C | PMID 9268299 | Open record: tissue-type plasminogen activator (single-chain tPA), N-benzyloxycarbonyl-D-phenylalanyl-glycyl-L-arginine 4-nitroanilide |
| tissue-type plasminogen activator (single-chain tPA) | Homo sapiens | N-benzyloxycarbonyl-L-alpha-aspartyl(beta-tert-butyl ester)-glycyl-L-arginine 4-nitroanilide | 1.84 | 2.3 | 0.8 | pH 8, 25 °C | PMID 9268299 | Open record: tissue-type plasminogen activator (single-chain tPA), N-benzyloxycarbonyl-L-alpha-aspartyl(beta-tert-butyl ester)-glycyl-L-arginine 4-nitroanilide |
| tissue-type plasminogen activator (single-chain tPA) | Homo sapiens | N-benzyloxycarbonyl-L-alpha-aspartyl-glycyl-L-arginine 4-nitroanilide | 0.35 | 0.72 | 0.49 | pH 8, 25 °C | PMID 9268299 | Open record: tissue-type plasminogen activator (single-chain tPA), N-benzyloxycarbonyl-L-alpha-aspartyl-glycyl-L-arginine 4-nitroanilide |
| tissue-type plasminogen activator (single-chain tPA) | Homo sapiens | N-benzyloxycarbonyl-L-alpha-glutamyl(gamma-tert-butyl ester)-glycyl-L-arginine 4-nitroanilide | 1.29 | 0.9 | 1.43 | pH 8, 25 °C | PMID 9268299 | Open record: tissue-type plasminogen activator (single-chain tPA), N-benzyloxycarbonyl-L-alpha-glutamyl(gamma-tert-butyl ester)-glycyl-L-arginine 4-nitroanilide |
| tissue-type plasminogen activator (single-chain tPA) | Homo sapiens | N-benzyloxycarbonyl-L-alpha-glutamyl-glycyl-L-arginine 4-nitroanilide | 0.75 | 2.2 | 0.34 | pH 8, 25 °C | PMID 9268299 | Open record: tissue-type plasminogen activator (single-chain tPA), N-benzyloxycarbonyl-L-alpha-glutamyl-glycyl-L-arginine 4-nitroanilide |
| tissue-type plasminogen activator (single-chain tPA) | Homo sapiens | N-benzyloxycarbonyl-L-valyl-glycyl-L-arginine 4-nitroanilide | 1.69 | 1.36 | 1.24 | pH 8, 25 °C | PMID 9268299 | Open record: tissue-type plasminogen activator (single-chain tPA), N-benzyloxycarbonyl-L-valyl-glycyl-L-arginine 4-nitroanilide |
| tissue-type plasminogen activator (single-chain tPA) | Homo sapiens | N-methoxycarbonyl-D-cyclohexylalanyl-glycyl-L-arginine 4-nitroanilide | 7.76 | 0.34 | 22.8 | pH 8, 25 °C | PMID 9268299 | Open record: tissue-type plasminogen activator (single-chain tPA), N-methoxycarbonyl-D-cyclohexylalanyl-glycyl-L-arginine 4-nitroanilide |
| tissue-type plasminogen activator (single-chain tPA) | Homo sapiens | N-methoxycarbonyl-D-cyclohexylglycyl-glycyl-L-arginine 4-nitroanilide | 5.02 | 0.42 | 11.9 | pH 8, 25 °C | PMID 9268299 | Open record: tissue-type plasminogen activator (single-chain tPA), N-methoxycarbonyl-D-cyclohexylglycyl-glycyl-L-arginine 4-nitroanilide |
| tissue-type plasminogen activator (single-chain tPA) | Homo sapiens | N-methoxycarbonyl-D-hexahydrotyrosyl-glycyl-L-arginine 4-nitroanilide | 8.31 | 0.39 | 21.3 | pH 8, 25 °C | PMID 9268299 | Open record: tissue-type plasminogen activator (single-chain tPA), N-methoxycarbonyl-D-hexahydrotyrosyl-glycyl-L-arginine 4-nitroanilide |
| tissue-type plasminogen activator (single-chain tPA) | Homo sapiens | N-methoxycarbonyl-D-leucyl-glycyl-L-arginine 4-nitroanilide | 6.92 | 0.62 | 11.2 | pH 8, 25 °C | PMID 9268299 | Open record: tissue-type plasminogen activator (single-chain tPA), N-methoxycarbonyl-D-leucyl-glycyl-L-arginine 4-nitroanilide |
| tissue-type plasminogen activator (single-chain tPA) | Homo sapiens | N-methoxycarbonyl-D-norleucyl-glycyl-L-arginine 4-nitroanilide | 6.82 | 0.99 | 6.89 | pH 8, 25 °C | PMID 9268299 | Open record: tissue-type plasminogen activator (single-chain tPA), N-methoxycarbonyl-D-norleucyl-glycyl-L-arginine 4-nitroanilide |
| tissue-type plasminogen activator (single-chain tPA) | Homo sapiens | N-methoxycarbonyl-D-valyl-glycyl-L-arginine 4-nitroanilide | 5.77 | 0.8 | 7.22 | pH 8, 25 °C | PMID 9268299 | Open record: tissue-type plasminogen activator (single-chain tPA), N-methoxycarbonyl-D-valyl-glycyl-L-arginine 4-nitroanilide |
| tissue-type plasminogen activator (single-chain tPA) | Homo sapiens | N-methylsulfonyl-D-phenylalanyl-glycyl-L-arginine 4-nitroanilide | 7.36 | 0.1 | 73.6 | pH 8, 25 °C | PMID 9268299 | Open record: tissue-type plasminogen activator (single-chain tPA), N-methylsulfonyl-D-phenylalanyl-glycyl-L-arginine 4-nitroanilide |
| tissue-type plasminogen activator (single-chain tPA) | Homo sapiens | N-tert-butoxycarbonyl-glycyl-glycyl-L-arginine 4-nitroanilide | 1.29 | 3.5 | 0.37 | pH 8, 25 °C | PMID 9268299 | Open record: tissue-type plasminogen activator (single-chain tPA), N-tert-butoxycarbonyl-glycyl-glycyl-L-arginine 4-nitroanilide |
| tissue-type plasminogen activator (single-chain tPA) | Homo sapiens | pyroglutamyl-glycyl-L-arginine 4-nitroanilide | 4.04 | 3.15 | 1.28 | pH 8, 25 °C | PMID 9268299 | Open record: tissue-type plasminogen activator (single-chain tPA), pyroglutamyl-glycyl-L-arginine 4-nitroanilide |
| tissue-type plasminogen activator (t-PA) | — | staphylococcal nuclease variant (I), residues 44-51 of the 43-52 loop replaced by PFGRSA | — | — | 0.029 | 37 °C | PMID 9468480 | Open record: tissue-type plasminogen activator (t-PA), staphylococcal nuclease variant (I), residues 44-51 of the 43-52 loop replaced by PFGRSA |
| tissue-type plasminogen activator (t-PA) | — | staphylococcal nuclease variant (II), residues 44-51 of the 43-52 loop replaced by PFGRSAG | 0.018 | 0.079 | 0.23 | 37 °C | PMID 9468480 | Open record: tissue-type plasminogen activator (t-PA), staphylococcal nuclease variant (II), residues 44-51 of the 43-52 loop replaced by PFGRSAG |
| tissue-type plasminogen activator (t-PA) | — | staphylococcal nuclease variant (III), residues 44-51 of the 43-52 loop replaced by PPFGRSAG | 0.011 | 0.0099 | 1.1 | 37 °C | PMID 9468480 | Open record: tissue-type plasminogen activator (t-PA), staphylococcal nuclease variant (III), residues 44-51 of the 43-52 loop replaced by PPFGRSAG |
| tissue-type plasminogen activator (t-PA) | — | staphylococcal nuclease variant (IV), residues 44-51 of the 43-52 loop replaced by PGPFGRSAG | 0.0075 | 0.0099 | 0.76 | 37 °C | PMID 9468480 | Open record: tissue-type plasminogen activator (t-PA), staphylococcal nuclease variant (IV), residues 44-51 of the 43-52 loop replaced by PGPFGRSAG |
| tissue-type plasminogen activator (t-PA) | — | staphylococcal nuclease variant (IX), residues 44-51 of the 43-52 loop replaced by PGSGRSASGTTGTG | — | — | 0.019 | 37 °C | PMID 9468480 | Open record: tissue-type plasminogen activator (t-PA), staphylococcal nuclease variant (IX), residues 44-51 of the 43-52 loop replaced by PGSGRSASGTTGTG |
| tissue-type plasminogen activator (t-PA) | — | staphylococcal nuclease variant (V), residues 44-51 of the 43-52 loop replaced by PGPFGRSAGG | 0.01 | 0.0093 | 1.1 | 37 °C | PMID 9468480 | Open record: tissue-type plasminogen activator (t-PA), staphylococcal nuclease variant (V), residues 44-51 of the 43-52 loop replaced by PGPFGRSAGG |
| tissue-type plasminogen activator (t-PA) | — | staphylococcal nuclease variant (VI), residues 44-51 of the 43-52 loop replaced by PHYGRSGG | 0.012 | 0.018 | 0.67 | 37 °C | PMID 9468480 | Open record: tissue-type plasminogen activator (t-PA), staphylococcal nuclease variant (VI), residues 44-51 of the 43-52 loop replaced by PHYGRSGG |
| tissue-type plasminogen activator (t-PA) | — | staphylococcal nuclease variant (VII), residues 44-51 of the 43-52 loop replaced by PQRGRSAG | 0.006 | 0.0089 | 0.67 | 37 °C | PMID 9468480 | Open record: tissue-type plasminogen activator (t-PA), staphylococcal nuclease variant (VII), residues 44-51 of the 43-52 loop replaced by PQRGRSAG |
| tissue-type plasminogen activator (t-PA) | — | staphylococcal nuclease variant (VIII), residues 44-51 of the 43-52 loop replaced by PGSGRSAG | 3.7 × 10⁻⁴ | 0.017 | 0.022 | 37 °C | PMID 9468480 | Open record: tissue-type plasminogen activator (t-PA), staphylococcal nuclease variant (VIII), residues 44-51 of the 43-52 loop replaced by PGSGRSAG |
| tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA) | — | (p-fluoro)Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl | 1.47 | 0.39 | 3.8 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), (p-fluoro)Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl |
| tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA) | — | D-Leu-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4) | 0.057 | 0.041 | 1.4 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), D-Leu-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4) |
| tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA) | — | D-Leu-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated) | 0.31 | 0.098 | 3.2 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), D-Leu-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated) |
| tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA) | — | D-Leu-Ser-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated) | 0.089 | 0.069 | 1.3 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), D-Leu-Ser-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated) |
| tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA) | — | D-Phe-Leu-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated) | 0.021 | 0.0074 | 2.9 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), D-Phe-Leu-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated) |
| tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA) | — | D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4) | 0.074 | 0.036 | 2.1 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4) |
| tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA) | — | D-Phe-Val-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl | 0.044 | 0.016 | 2.7 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), D-Phe-Val-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl |
| tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA) | — | D-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated) | 0.082 | 0.058 | 1.4 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), D-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated) |
| tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA) | — | D-Val-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated) | 0.71 | 0.11 | 6.4 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), D-Val-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated) |
| tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA) | — | L-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl | 0.04 | 0.97 | 0.04 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), L-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl |
| tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA) | — | L-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated) | 0.08 | 0.46 | 0.18 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), L-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated) |
| tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA) | — | tert-butyloxycarbonyl-D-Leu-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4) | 0.097 | 0.015 | 6.3 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), tert-butyloxycarbonyl-D-Leu-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4) |
| tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA) | — | tert-butyloxycarbonyl-D-Leu-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated) | 0.54 | 0.066 | 8.2 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), tert-butyloxycarbonyl-D-Leu-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated) |
| tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA) | — | tert-butyloxycarbonyl-D-Leu-Ser-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated) | 0.53 | 0.36 | 1.5 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), tert-butyloxycarbonyl-D-Leu-Ser-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated) |
| tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA) | — | tert-butyloxycarbonyl-D-Phe-Leu-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated) | 0.1 | 0.03 | 3.3 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), tert-butyloxycarbonyl-D-Phe-Leu-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated) |
| tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA) | — | tert-butyloxycarbonyl-D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4) | 0.15 | 0.047 | 3.2 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), tert-butyloxycarbonyl-D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4) |
| tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA) | — | tert-butyloxycarbonyl-D-Phe-Val-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl | 0.49 | 0.091 | 5.4 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), tert-butyloxycarbonyl-D-Phe-Val-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl |
| tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA) | — | tert-butyloxycarbonyl-D-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated) | 0.34 | 0.14 | 2.4 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), tert-butyloxycarbonyl-D-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated) |
| tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA) | — | tert-butyloxycarbonyl-D-Val-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated) | 0.25 | 0.026 | 9.5 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), tert-butyloxycarbonyl-D-Val-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated) |
| tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA) | — | tert-butyloxycarbonyl-L-(p-fluoro)Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl | 1.03 | 0.071 | 14.6 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), tert-butyloxycarbonyl-L-(p-fluoro)Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl |
| tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA) | — | tert-butyloxycarbonyl-L-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl | 0.011 | 0.047 | 0.24 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), tert-butyloxycarbonyl-L-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl |
| tissue-type plasminogen activator (tPA)variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA) | — | tert-butyloxycarbonyl-L-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated) | 0.084 | 0.1 | 0.83 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant sc-tPA/tc-tPA mixture (80% sc-tPA, 20% tc-tPA), tert-butyloxycarbonyl-L-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated) |
| tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA) | — | (p-fluoro)Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl | 0.37 | 0.011 | 32.8 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), (p-fluoro)Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl |
| tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA) | — | D-Leu-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4) | 0.034 | 0.011 | 3 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Leu-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4) |
| tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA) | — | D-Leu-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated) | 0.17 | 0.012 | 14.2 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Leu-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated) |
| tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA) | — | D-Leu-Ser-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated) | 0.1 | 0.017 | 6.2 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Leu-Ser-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated) |
| tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA) | — | D-Phe-Leu-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated) | 0.018 | 0.01 | 1.9 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Leu-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated) |
| tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA) | — | D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N,N-diethyl (Table 4: D-FPR-ANSNR1R2 with R1 = C2H5, R2 = C2H5) | 0.14 | 0.12 | 1.2 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N,N-diethyl (Table 4: D-FPR-ANSNR1R2 with R1 = C2H5, R2 = C2H5) |
| tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA) | — | D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N,N-hexamethylene (R1R2 = (CH2)6 ring) (Table 4: D-FPR-ANSNR1R2 with R1R2 = (CH2)6) | 0.22 | 0.096 | 2.3 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N,N-hexamethylene (R1R2 = (CH2)6 ring) (Table 4: D-FPR-ANSNR1R2 with R1R2 = (CH2)6) |
| tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA) | — | D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-(2-methoxyethyl) (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = C2H4OCH3) | 0.66 | 0.14 | 4.7 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-(2-methoxyethyl) (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = C2H4OCH3) |
| tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA) | — | D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-(methoxycarbonylmethyl), i.e. glycine methyl ester (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = CH2COOCH3) | 0.15 | 0.029 | 5.2 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-(methoxycarbonylmethyl), i.e. glycine methyl ester (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = CH2COOCH3) |
| tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA) | — | D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-benzyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = C6H5CH2) | 0.54 | 0.025 | 21.6 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-benzyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = C6H5CH2) |
| tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA) | — | D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4) | 0.51 | 0.077 | 6.6 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4) |
| tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA) | — | D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = c-C6H11) | 0.32 | 0.088 | 3.6 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = c-C6H11) |
| tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA) | — | D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-isopropyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = i-C3H7) | 0.2 | 0.074 | 2.7 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-isopropyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = i-C3H7) |
| tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA) | — | D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-n-butyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = n-C4H9) | 0.47 | 0.048 | 9.8 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-n-butyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = n-C4H9) |
| tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA) | — | D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-n-hexyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = n-C6H13) | 3.6 | 0.095 | 37.9 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-n-hexyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = n-C6H13) |
| tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA) | — | D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-tert-butyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = t-C4H9) | 0.94 | 0.084 | 11.2 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-tert-butyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = t-C4H9) |
| tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA) | — | D-Phe-Val-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl | 0.025 | 0.0078 | 3.2 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Phe-Val-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl |
| tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA) | — | D-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated) | 0.19 | 0.033 | 5.8 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated) |
| tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA) | — | D-Val-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated) | 0.16 | 0.0081 | 20.2 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), D-Val-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated) |
| tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA) | — | tert-butyloxycarbonyl-D-Leu-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4) | 0.04 | 0.0085 | 4.7 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), tert-butyloxycarbonyl-D-Leu-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4) |
| tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA) | — | tert-butyloxycarbonyl-D-Leu-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated) | 0.2 | 0.0088 | 23.2 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), tert-butyloxycarbonyl-D-Leu-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated) |
| tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA) | — | tert-butyloxycarbonyl-D-Leu-Ser-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated) | 0.097 | 0.013 | 7.3 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), tert-butyloxycarbonyl-D-Leu-Ser-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated) |
| tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA) | — | tert-butyloxycarbonyl-D-Phe-Leu-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated) | 0.047 | 0.013 | 3.6 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), tert-butyloxycarbonyl-D-Phe-Leu-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated) |
| tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA) | — | tert-butyloxycarbonyl-D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4) | 0.017 | 0.0026 | 6.4 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), tert-butyloxycarbonyl-D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4) |
| tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA) | — | tert-butyloxycarbonyl-D-Phe-Val-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl | 0.15 | 0.032 | 4.8 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), tert-butyloxycarbonyl-D-Phe-Val-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl |
| tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA) | — | tert-butyloxycarbonyl-D-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated) | 0.18 | 0.014 | 12.8 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), tert-butyloxycarbonyl-D-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated) |
| tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA) | — | tert-butyloxycarbonyl-D-Val-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated) | 0.25 | 0.015 | 16.5 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), tert-butyloxycarbonyl-D-Val-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated) |
| tissue-type plasminogen activator (tPA)variant two-chain tPA (tc-tPA) | — | tert-butyloxycarbonyl-L-(p-fluoro)Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl | 0.44 | 0.0066 | 66.5 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) variant two-chain tPA (tc-tPA), tert-butyloxycarbonyl-L-(p-fluoro)Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl |
| tissue-type plasminogen activator (tPA) | Homo sapiens | human plasminogenporcine | — | — | 190 | pH 7.4, 37 °C | PMID 41567719 | Open record: tissue-type plasminogen activator (tPA), human plasminogen |
| tissue-type plasminogen activator (tPA) | Homo sapiens | human plasminogenhuman | — | — | 440 | pH 7.4, 37 °C | PMID 41567719 | Open record: tissue-type plasminogen activator (tPA), human plasminogen |
| tissue-type plasminogen activator (tPA) | Homo sapiens | porcine plasminogenporcine | — | — | 3.3 | pH 7.4, 37 °C | PMID 41567719 | Open record: tissue-type plasminogen activator (tPA), porcine plasminogen |
| tissue-type plasminogen activator (tPA) | Homo sapiens | porcine plasminogenhuman | — | — | 33 | pH 7.4, 37 °C | PMID 41567719 | Open record: tissue-type plasminogen activator (tPA), porcine plasminogen |
| tissue-type plasminogen activator (tPA) | Sus scrofa | human plasminogenporcine | — | — | 26 | pH 7.4, 37 °C | PMID 41567719 | Open record: tissue-type plasminogen activator (tPA), human plasminogen |
| tissue-type plasminogen activator (tPA) | Sus scrofa | human plasminogenhuman | — | — | 880 | pH 7.4, 37 °C | PMID 41567719 | Open record: tissue-type plasminogen activator (tPA), human plasminogen |
| tissue-type plasminogen activator (tPA) | Sus scrofa | porcine plasminogenporcine | — | — | 18 | pH 7.4, 37 °C | PMID 41567719 | Open record: tissue-type plasminogen activator (tPA), porcine plasminogen |
| tissue-type plasminogen activator (tPA) | Sus scrofa | porcine plasminogenhuman | — | — | 36 | pH 7.4, 37 °C | PMID 41567719 | Open record: tissue-type plasminogen activator (tPA), porcine plasminogen |
| tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA) | — | (p-fluoro)Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl | 0.099 | 0.026 | 3.7 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), (p-fluoro)Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl |
| tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA) | — | D-Leu-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4) | 0.0084 | 0.011 | 0.71 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Leu-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4) |
| tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA) | — | D-Leu-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated) | 0.061 | 0.04 | 1.5 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Leu-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated) |
| tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA) | — | D-Leu-Ser-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated) | 0.019 | 0.014 | 1.3 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Leu-Ser-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated) |
| tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA) | — | D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N,N-diethyl (Table 4: D-FPR-ANSNR1R2 with R1 = C2H5, R2 = C2H5) | 0.09 | 0.32 | 0.28 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N,N-diethyl (Table 4: D-FPR-ANSNR1R2 with R1 = C2H5, R2 = C2H5) |
| tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA) | — | D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N,N-hexamethylene (R1R2 = (CH2)6 ring) (Table 4: D-FPR-ANSNR1R2 with R1R2 = (CH2)6) | 0.13 | 0.25 | 0.52 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N,N-hexamethylene (R1R2 = (CH2)6 ring) (Table 4: D-FPR-ANSNR1R2 with R1R2 = (CH2)6) |
| tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA) | — | D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-(2-methoxyethyl) (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = C2H4OCH3) | 0.27 | 0.18 | 1.5 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-(2-methoxyethyl) (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = C2H4OCH3) |
| tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA) | — | D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-(methoxycarbonylmethyl), i.e. glycine methyl ester (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = CH2COOCH3) | 0.083 | 0.063 | 1.3 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-(methoxycarbonylmethyl), i.e. glycine methyl ester (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = CH2COOCH3) |
| tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA) | — | D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-benzyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = C6H5CH2) | 0.45 | 0.063 | 7.1 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-benzyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = C6H5CH2) |
| tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA) | — | D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4) | 0.016 | 0.0057 | 2.8 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4) |
| tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA) | — | D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = c-C6H11) | 0.15 | 0.15 | 1 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = c-C6H11) |
| tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA) | — | D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-isopropyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = i-C3H7) | 0.29 | 0.33 | 0.88 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-isopropyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = i-C3H7) |
| tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA) | — | D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-n-butyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = n-C4H9) | 0.33 | 0.12 | 2.8 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-n-butyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = n-C4H9) |
| tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA) | — | D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-n-hexyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = n-C6H13) | 1.1 | 0.099 | 11.1 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-n-hexyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = n-C6H13) |
| tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA) | — | D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-tert-butyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = t-C4H9) | 0.25 | 0.079 | 3.2 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-tert-butyl (Table 4: D-FPR-ANSNR1R2 with R1 = H, R2 = t-C4H9) |
| tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA) | — | D-Phe-Val-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl | 0.011 | 0.0073 | 1.5 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Phe-Val-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl |
| tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA) | — | D-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated) | 0.021 | 0.022 | 0.95 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated) |
| tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA) | — | D-Val-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated) | 0.059 | 0.025 | 2.3 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), D-Val-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated) |
| tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA) | — | tert-butyloxycarbonyl-D-Leu-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4) | 0.012 | 0.023 | 0.51 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), tert-butyloxycarbonyl-D-Leu-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-cyclohexyl (C6H11; c-C6H11 per Table 4) |
| tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA) | — | tert-butyloxycarbonyl-D-Leu-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated) | 0.038 | 0.015 | 2.5 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), tert-butyloxycarbonyl-D-Leu-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated) |
| tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA) | — | tert-butyloxycarbonyl-D-Leu-Ser-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated) | 0.022 | 0.02 | 1.1 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), tert-butyloxycarbonyl-D-Leu-Ser-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated) |
| tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA) | — | tert-butyloxycarbonyl-D-Phe-Leu-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated) | 0.01 | 0.017 | 0.6 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), tert-butyloxycarbonyl-D-Phe-Leu-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C3H7 (propyl, isomer not stated) |
| tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA) | — | tert-butyloxycarbonyl-D-Phe-Val-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl | 0.019 | 0.012 | 1.7 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), tert-butyloxycarbonyl-D-Phe-Val-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl |
| tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA) | — | tert-butyloxycarbonyl-D-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated) | 0.036 | 0.019 | 1.9 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), tert-butyloxycarbonyl-D-Val-Gly-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated) |
| tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA) | — | tert-butyloxycarbonyl-D-Val-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated) | 0.065 | 0.029 | 2.3 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), tert-butyloxycarbonyl-D-Val-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-C4H9 (butyl, isomer not stated) |
| tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA) | — | tert-butyloxycarbonyl-L-(p-fluoro)Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl | 0.11 | 0.016 | 7.1 | pH 7.4, 25 °C | PMID 9047311 | Open record: tissue-type plasminogen activator (tPA) single-chain tPA (sc-tPA), tert-butyloxycarbonyl-L-(p-fluoro)Phe-Pro-Arg 6-amino-1-naphthalenesulfonamide (ANSN) leaving group, sulfonamide N-ethyl |